Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kluth

Showing results (591-600 of 1,145) with videos related to

Pageof 115
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 8, 2013
Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomyEvanguelos Xylinas, Michael Rink, Brian D Robinson, et al.
Urologic Oncology|March 7, 2018
Conditional analyses of recurrence and progression in patients with TaG1 non-muscle-invasive bladder cancerNicolas von Landenberg, Atiqullah Aziz, Friedrich C von Rundstedt, et al.
Clinical Genitourinary Cancer|April 15, 2018
Predictors of Cancer-specific Survival After Disease Recurrence in Patients With Renal Cell Carcinoma: The Effect of Time to RecurrenceMalte Rieken, Luis A Kluth, Harun Fajkovic, et al.
BJU International|September 24, 2013
Impact of smoking status and cumulative exposure on intravesical recurrence of upper tract urothelial carcinoma after radical nephroureterectomyEvanguelos Xylinas, Luis A Kluth, Malte Rieken, et al.
BJU International|September 24, 2013
Impact of peri-operative blood transfusion on the outcomes of patients undergoing radical cystectomy for urothelial carcinoma of the bladderLuis A Kluth, Evanguelos Xylinas, Malte Rieken, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 27, 2013
High nuclear karyopherin α 2 expression is a strong and independent predictor of biochemical recurrence in prostate cancer patients treated by radical prostatectomyKatharina Grupp, Mareike Habermann, Hüseyin Sirma, et al.
European Urology Focus|December 28, 2020
Comparison of Complication Rates with Antibiotic Prophylaxis with Cefpodoxime Versus Fluoroquinolones After Transrectal Prostate BiopsyMike Wenzel, Maria N Welte, Lena H Theissen, et al.
European Journal of Cancer (Oxford, England : 1990)|August 15, 2021
Median time to progression with TKI-based therapy after failure of immuno-oncology therapy in metastatic kidney cancer: A systematic review and meta-analysisMike Wenzel, Marina Deuker, Luigi Nocera, et al.
Current Oncology (Toronto, Ont.)|July 2, 2021
Immunohistochemistry for Prostate Biopsy-Impact on Histological Prostate Cancer Diagnoses and Clinical Decision MakingPhilipp Mandel, Mike Wenzel, Benedikt Hoeh, et al.
Prostate International|March 9, 2022
Up- and downgrading in single intermediate-risk positive biopsy core prostate cancerBenedikt Hoeh, Rocco Flammia, Lukas Hohenhorst, et al.
Pageof 115

Showing results (591-600 of 1,145) with videos related to

Sort By:
Pageof 115
European Journal of Cancer (Oxford, England : 1990)|March 8, 2013
Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomyEvanguelos Xylinas, Michael Rink, Brian D Robinson, et al.
Urologic Oncology|March 7, 2018
Conditional analyses of recurrence and progression in patients with TaG1 non-muscle-invasive bladder cancerNicolas von Landenberg, Atiqullah Aziz, Friedrich C von Rundstedt, et al.
Clinical Genitourinary Cancer|April 15, 2018
Predictors of Cancer-specific Survival After Disease Recurrence in Patients With Renal Cell Carcinoma: The Effect of Time to RecurrenceMalte Rieken, Luis A Kluth, Harun Fajkovic, et al.
BJU International|September 24, 2013
Impact of smoking status and cumulative exposure on intravesical recurrence of upper tract urothelial carcinoma after radical nephroureterectomyEvanguelos Xylinas, Luis A Kluth, Malte Rieken, et al.
BJU International|September 24, 2013
Impact of peri-operative blood transfusion on the outcomes of patients undergoing radical cystectomy for urothelial carcinoma of the bladderLuis A Kluth, Evanguelos Xylinas, Malte Rieken, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 27, 2013
High nuclear karyopherin α 2 expression is a strong and independent predictor of biochemical recurrence in prostate cancer patients treated by radical prostatectomyKatharina Grupp, Mareike Habermann, Hüseyin Sirma, et al.
European Urology Focus|December 28, 2020
Comparison of Complication Rates with Antibiotic Prophylaxis with Cefpodoxime Versus Fluoroquinolones After Transrectal Prostate BiopsyMike Wenzel, Maria N Welte, Lena H Theissen, et al.
European Journal of Cancer (Oxford, England : 1990)|August 15, 2021
Median time to progression with TKI-based therapy after failure of immuno-oncology therapy in metastatic kidney cancer: A systematic review and meta-analysisMike Wenzel, Marina Deuker, Luigi Nocera, et al.
Current Oncology (Toronto, Ont.)|July 2, 2021
Immunohistochemistry for Prostate Biopsy-Impact on Histological Prostate Cancer Diagnoses and Clinical Decision MakingPhilipp Mandel, Mike Wenzel, Benedikt Hoeh, et al.
Prostate International|March 9, 2022
Up- and downgrading in single intermediate-risk positive biopsy core prostate cancerBenedikt Hoeh, Rocco Flammia, Lukas Hohenhorst, et al.
Pageof 115